Clinical Trials Browser

Phase 1/2 × OTHER × relmacabtagene autoleucel × Clear all

NCT05370547 2024-03-06

Chidamide Bridging for CAR-T Therapy

Phase 1/2 Recruiting

Lymphoma, Non-Hodgkin